North America Human Leukocyte Antigen Typing For Transplant Market to 2032
Overview
The North America Human Leukocyte Antigen Typing For Transplant Market is expected to reach a 876.28 USD Million by 2032 and is projected to grow at a CAGR of 12.88% from 2025 to 2032.
Revenue, 2024 (USD Million)
450.64
Forecast, 2032 (USD Million)
876.28
CAGR, 2024 - 2032
12.88%
Report Coverage
North America
North America Human Leukocyte Antigen Typing For Transplant Market 2018-2032 USD Million
North America Human Leukocyte Antigen Typing For Transplant Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 450.64 USD Million
- Projected Market Size (2032): 876.28 USD Million
- CAGR (2025-2032): 12.88%
Key Findings of North America Human Leukocyte Antigen Typing For Transplant Market
- The North America Human Leukocyte Antigen Typing For Transplant Market was valued at 450.64 USD Million in 2024.
- The North America Human Leukocyte Antigen Typing For Transplant Market is likely to grow at a CAGR of 12.88% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Molecular Assay Technologies in Technology Segment accounted for the largest share of the market with a revenue of 370.27 USD Million
- The fastest growing segment Hospitals & Transplant Centers in End Users Segment grew Fastest with a CAGR of 14.30% during the forecast period from 2024 to 2032.
North America Human Leukocyte Antigen Typing For Transplant Market Scope
North America Human Leukocyte Antigen Typing For Transplant Market Segmentation & Scope
End Users
- Independent Reference Laboratories
- Research Laboratories & Academic Institutes
- Hospitals & Transplant Centers
Application
- Research Applications
- Diagnostic Applications
Transplant Type
- Hematopoietic Stem Cell Transplant
- Solid Organ Transplant
Technology
- Non-Molecular Assay Technologies
- Molecular Assay Technologies
Products & Services
- Software & Services
- Reagents and Consumables
- Instruments
North America Human Leukocyte Antigen Typing For Transplant Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 450.64 USD Million |
| Market Value in 2032 | 876.28 USD Million |
| CAGR (2025-2032) | 12.88% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End Users,Application,Transplant Type,Technology,Products & Services |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 450.64 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 378.34 USD Million in 2024.
Segments and Scope
-
North America Human Leukocyte Antigen Typing For Transplant Market to 2032, By End Users
- Hospitals & Transplant Centers is the largest segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 235.88 USD Million in the year 2024.
- Hospitals & Transplant Centers is the Fastest growing segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 14.30 % in forecast period 2025-2032.
-
North America Human Leukocyte Antigen Typing For Transplant Market to 2032, By Application
- Diagnostic Applications is the largest segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 271.50 USD Million in the year 2024.
- Diagnostic Applications is the Fastest growing segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 13.63 % in forecast period 2025-2032.
-
North America Human Leukocyte Antigen Typing For Transplant Market to 2032, By Transplant Type
- Solid Organ Transplant is the largest segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 294.12 USD Million in the year 2024.
- Solid Organ Transplant is the Fastest growing segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 13.49 % in forecast period 2025-2032.
-
North America Human Leukocyte Antigen Typing For Transplant Market to 2032, By Technology
- Molecular Assay Technologies is the largest segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 370.27 USD Million in the year 2024.
- Molecular Assay Technologies is the Fastest growing segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 13.40 % in forecast period 2025-2032.
-
North America Human Leukocyte Antigen Typing For Transplant Market to 2032, By Products & Services
- Instruments is the largest segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a revenue of 229.57 USD Million in the year 2024.
- Reagents and Consumables is the Fastest growing segment in North America Human Leukocyte Antigen Typing For Transplant Market to 2032 with a Growth rate of 11.93 % in forecast period 2025-2032.
North America Human Leukocyte Antigen Typing For Transplant Market Company Share Analysis
| Company Name |
|
||
| Membrane Solutions, LLC. | |||
| Porex | |||
| SARTORIUS AG | |||
North America Human Leukocyte Antigen Typing For Transplant Market Geographical Sales Distribution, 2018-2032 USD Million
North America Human Leukocyte Antigen Typing For Transplant Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation End Users,Application,Transplant Type,Technology,Products & Services.
North America Human Leukocyte Antigen Typing For Transplant Market was valued at USD 450.64(Revenue in USD Million) in 2020.
North America Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 12.88% during the forecast period of 2024 to 2032.
The Molecular Assay Technologies segment is expected to dominate the North America Human Leukocyte Antigen Typing For Transplant Market, holding a largest market share of 370.27 USD Million in 2024
Coming Soon....
North America Human Leukocyte Antigen Typing For Transplant Market Scope
North America Human Leukocyte Antigen Typing For Transplant Market Segmentation & Scope
End Users
- Independent Reference Laboratories
- Research Laboratories & Academic Institutes
- Hospitals & Transplant Centers
Application
- Research Applications
- Diagnostic Applications
Transplant Type
- Hematopoietic Stem Cell Transplant
- Solid Organ Transplant
Technology
- Non-Molecular Assay Technologies
- Molecular Assay Technologies
Products & Services
- Software & Services
- Reagents and Consumables
- Instruments
Frequently Asked Questions
The North America Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation End Users,Application,Transplant Type,Technology,Products & Services.
North America Human Leukocyte Antigen Typing For Transplant Market was valued at USD 450.64(Revenue in USD Million) in 2020.
North America Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 12.88% during the forecast period of 2024 to 2032.
The estimated market value of the North America Human Leukocyte Antigen Typing For Transplant Market for final year is USD 876.28 (USD Million).
North America Human Leukocyte Antigen Typing For Transplant Market Company Profiling
Frequently Asked Questions
The North America Human Leukocyte Antigen Typing For Transplant Market is segmented based on Segmentation End Users,Application,Transplant Type,Technology,Products & Services.
North America Human Leukocyte Antigen Typing For Transplant Market was valued at USD 450.64(Revenue in USD Million) in 2020.
North America Human Leukocyte Antigen Typing For Transplant Market is projected to grow at a CAGR of 12.88% during the forecast period of 2024 to 2032.
The estimated market value of the North America Human Leukocyte Antigen Typing For Transplant Market for final year is USD 876.28 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.